EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Bilateral Thalamic Diffuse Midline Glioma, H3K27M‐Altered, in a 3‐Year‐Old Boy

Ammir Abuzahra iD, Bessan N Abuzahra iD, Ruba Atawneh iD, Siwar Abu Sakout iD, Raya Abu Ayyash iD, Jana Dwaik iD, Mohammad Y Nairokh iD, Nasim Abukaresh iD

Clinical Case Reports · 2026-06 · 14 (6)

DOI: 10.1002/ccr3.72770 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Case Reports, online erschienen am 22.05.2026. Verfasst von Ammir Abuzahra und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, College of Medicine Hebron University Hebron Palestine. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diffuse midline glioma, H3 K27‐altered, is an aggressive pediatric brain tumor that can mimic non‐neoplastic conditions when located outside the brainstem. We describe a 3‐year‐old boy who presented with progressive ocular misalignment and left‐sided weakness without systemic symptoms. Magnetic resonance imaging demonstrated symmetric bilateral thalamic T2/FLAIR hyperintense lesions without contrast enhancement or diffusion restriction, initially raising suspicion for inflammatory or metabolic disease. Cerebrospinal fluid and metabolic investigations were unremarkable. Due to diagnostic uncertainty, surgical resection of the dominant lesion was performed. Histopathology revealed an infiltrative high‐grade astrocytic tumor with loss of H3K27me3 and positive H3K27M immunostaining, confirming diffuse midline glioma, H3 K27‐altered (WHO grade IV). Postoperatively, the patient developed transient contralateral weakness but remained neurologically stable at 3‐month follow‐up and was referred for radiochemotherapy. This case highlights that bilateral thalamic lesions in children may represent diffuse midline glioma even when imaging lacks typical malignant features. Early biopsy should be considered in unexplained bilateral thalamic lesions to prevent diagnostic delay and initiate appropriate oncologic management.

Schlagwörter

Stichwörter der Autor:innen

H3 K27‐alteredWHO CNS classificationbilateral thalamic gliomadiffuse midline gliomapediatric brain tumor

Autor:innen und Institutionen

  • Department of Neurosurgery, College of Medicine Hebron University Hebron Palestine.
  • Department of Radiology Princess Alia Hebron Governmental Hospital Hebron West Bank Palestine.
  • Department of Radiology Red Crescent Palestinian Society Hebron Palestine.
  • College of Medicine and Health Sciences Palestine Polytechnic University Hebron Palestine.
  • Clinical Research Palestinian Clinical Research Center Bethlehem Palestine.

ORCID-Profile: Ammir Abuzahra, Bessan N Abuzahra, Ruba Atawneh, Siwar Abu Sakout, Raya Abu Ayyash, Jana Dwaik, Mohammad Y Nairokh, Nasim Abukaresh

Zitieren

APA

Abuzahra, A., Abuzahra, B. N., Atawneh, R., Abu Sakout, S., Abu Ayyash, R., Dwaik, J., Nairokh, M. Y., & Abukaresh, N. (2026). Bilateral Thalamic Diffuse Midline Glioma, H3K27M‐Altered, in a 3‐Year‐Old Boy. Clinical Case Reports, 14(6). https://doi.org/10.1002/ccr3.72770

Vancouver

Abuzahra A, Abuzahra BN, Atawneh R, Abu Sakout S, Abu Ayyash R, Dwaik J, et al. Bilateral Thalamic Diffuse Midline Glioma, H3K27M‐Altered, in a 3‐Year‐Old Boy. Clinical Case Reports. 2026;14(6). doi:10.1002/ccr3.72770

BibTeX
@article{Abuzahra2026,
  author = {Abuzahra, Ammir and Abuzahra, Bessan N and Atawneh, Ruba and Abu Sakout, Siwar and Abu Ayyash, Raya and Dwaik, Jana and Nairokh, Mohammad Y and Abukaresh, Nasim},
  title = {Bilateral Thalamic Diffuse Midline Glioma, H3K27M‐Altered, in a 3‐Year‐Old Boy},
  journal = {Clinical Case Reports},
  year = {2026},
  volume = {14},
  number = {6},
  doi = {10.1002/ccr3.72770}
}
Kostenlos starten →